Comparison of Two Biological Aortic Valves. Mosaic Ultra and Trifecta.
NCT ID: NCT01707927
Last Updated: 2014-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2012-09-30
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Severe Aortic Stenosis in Patients Referred for Valve Surgery
NCT01794832
Aortic Stenosis Evaluated Via Modern Ballistocardiography and Seismocardiography
NCT04231201
Interest of Pulse Wave Velocity Measurement as a Predictor of Severity of Aortic Stenosis
NCT03140735
Clinical Outcome of Patients With Low-gradient Severe Aortic Stenosis
NCT02010177
In-vitro Benchmarking of Currently Available Heart Valve Prostheses for Surgical and Percutaneous Treatment of Aortic Stenosis With Small Annulus, Followed by In-vivo Validation
NCT06859255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trifecta
Degenerated aortic valve with indication for aortic valve replacement
No interventions assigned to this group
mosaic Ultra
Need a aortic valve replacement
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Breast feeding
3. Aortic valve bigger than 23 mm
4. Endocarditis
5. EF \< 50%
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bjørn Braathen
MD. Ph.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bjørn Braathen, MD Ph.D
Role: PRINCIPAL_INVESTIGATOR
OUS Thoraxkirurgisk avdeling Ullevål
Theis Tønnessen, MD Ph.D
Role: STUDY_DIRECTOR
OUS thoraxkirurgisk avdeling Ullevål
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo university hospital, Thoracic departement
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/2596/REK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.